Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features

NCT05255653 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

1615

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: Olaparib
RADIATION: Pelvic external beam radiotherapy
DRUG: Chemotherapy
DRUG: Durvalumab
DRUG: Medroxyprogesterone Acetate
DRUG: Megestrol Acetate
RADIATION: Vaginal brachytherapy
OTHER: Observation

Sponsor

Leiden University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]